PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 74 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $292,000 | -7.0% | 479,800 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $314,000 | +112.2% | 479,800 | 0.0% | 0.00% | – |
Q4 2016 | $148,000 | -28.2% | 479,800 | 0.0% | 0.00% | – |
Q3 2016 | $206,000 | +17.7% | 479,800 | 0.0% | 0.00% | – |
Q2 2016 | $175,000 | -13.4% | 479,800 | 0.0% | 0.00% | – |
Q1 2016 | $202,000 | -64.0% | 479,800 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $561,000 | +14.7% | 479,800 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $489,000 | -22.3% | 479,800 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $629,000 | -1.4% | 479,800 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $638,000 | 0.0% | 479,800 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $638,000 | -2.3% | 479,800 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $653,000 | -27.6% | 479,800 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $902,000 | +64.3% | 479,800 | +65.0% | 0.00% | 0.0% |
Q1 2014 | $549,000 | +37.9% | 290,800 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $398,000 | -4.8% | 290,800 | -2.0% | 0.00% | 0.0% |
Q3 2013 | $418,000 | +214.3% | 296,800 | +188.2% | 0.00% | – |
Q2 2013 | $133,000 | – | 103,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tappan Street Partners LLC | 11,593,530 | $7,049,000 | 20.61% |
Bandera Partners LLC | 1,421,000 | $864,000 | 0.78% |
Brown Advisory Securities, LLC | 580,000 | $353,000 | 0.08% |
Sterling Global Strategies LLC | 20,000 | $12,000 | 0.06% |
Freedom Investment Management, Inc. | 1,052,770 | $642,000 | 0.04% |
BAXTER BROS INC | 150,500 | $92,000 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 576,897 | $351,000 | 0.01% |
Ballentine Partners, LLC | 25,001 | $113,000 | 0.01% |
LEVEL FOUR ADVISORY SERVICES, LLC | 57,700 | $37,000 | 0.01% |
Spark Investment Management LLC | 128,600 | $78,000 | 0.01% |